Search Results 121-130 of 18450 for crohn's disease

1. A Study of the Effectiveness and Safety of Mongersen (GED-0301) for the Treatment of Patients with Active Crohn's Disease - Mayo Clinic

   The purpose of this study is to test the effectiveness and safety of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease ...

2. Video Audio Inflammatory bowel disease, or IBD, is a broad term for chronic inflammation of your digestive tract. Two types

   Two types are Crohn's disease and ulcerative colitis. Amanda Johnson, M.D.. Gastroenterology. Mayo Clinic. “Ulcerative colitis really tends to only involve the.

3. Mayo Clinic Q&A podcast Dr. Faubion IBD

   It's actually quite a common disease. If you take a look at all forms of inflammatory bowel disease, both Crohn's disease and ulcerative colitis, the incidence ...

4. Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease - Mayo Clinic

   ... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

5. Crohn's disease - Doctors and departments - Mayo Clinic

   Departments that treat this condition · Colon and Rectal Surgery · Gastroenterology and Hepatology · Inflammatory Bowel Disease Clinic · Laboratory Medicine and ...

6. A Study to Evaluate the Effectiveness and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation - Mayo Clinic

   The purpose of this study is to evaluate the effects, safety and how OPS-2071 (150, 300, or 600 mg twice a day [BID]) is as an add-on therapy in Crohn's disease ...

7. Immuno-Epigenetics: William A. Faubion Jr.

   ... the autoimmune inflammatory bowel diseases (IBDs), such as Crohn's disease (CD) and ulcerative colitis (UC). Despite some genetic variation associated with IBD ...

8. Stem Cell Fistula Plug in Perianal Crohn's Disease - Mayo Clinic

   ... Crohn's disease will be enrolled. Subjects will undergo standard adjuvant therapy including drainage of infection and placement of a draining seton with ...

9. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

   The purpose of this extension study is to evaluate the safety and effectiveness of ozanimod in subjects with moderately to severely active Crohn's Disease.

10. Expert alert: Keep your gut healthy and avoid inflammatory disease - Mayo Clinic News Network

    — A healthy gut helps lower your risk of developing inflammatory diseases such as inflammatory bowel disease (IBD), a chronic condition that causes inflammation ...